ReviewFrontiers in immunology2026
Follicular dendritic cell sarcoma associated with IgG4-related disease: a case report and literature review.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Follicular dendritic cell sarcoma (FDCS) is a rare malignant tumor involving lymph nodes and extranodal sites, classified into conventional and inflammatory pseudotumor (IPT)-like variants. The IPT-like variant predominantly involves the liver and spleen. Immunoglobulin G4-related disease (IgG4-RD) is a systemic immune-mediated disorder characterized by multiorgan involvement, whereas isolated esophageal and gastric involvement is exceedingly rare. Although FDCS may exhibit infiltration of IgG4-positive plasma cells, the coexistence of FDCS and IgG4-RD has not been previously reported. Herein, we describe a unique case of FDCS associated with IgG4-RD involving the liver, esophagus, and stomach. The patient initially presented with hepatic lesions and gastrointestinal ulcers, accompanied by elevated serum IgG4 levels and histopathological features suggestive of IgG4-RD. Following glucocorticoid and immunosuppressive therapy, gastrointestinal lesions improved; however, the hepatic lesion progressed and was subsequently confirmed as FDCS by histopathology and immunohistochemistry. This case highlights the diagnostic challenges posed by overlapping clinicopathological features between FDCS and IgG4-RD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.